Early clinical trials investigating the effects of nutraceuticals formulated with probiotic strains and red yeast rice extract for 12 weeks have found promising results in improving cardiovascular risk-related parameters, such as the lipid profile and markers of atherosclerosis, such as ox-LDL and apolipoprotein B [203,204]. This evidence concerns the gene APOB and atherosclerosis.